Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.
Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Efe C, et al. Among authors: heurgue berlot a. Liver Int. 2022 Mar;42(3):607-614. doi: 10.1111/liv.15121. Epub 2021 Dec 13. Liver Int. 2022. PMID: 34846800
Late autoimmune hepatitis after hepatitis C therapy.
Efe C, Heurgué-Berlot A, Ozaslan E, Purnak T, Thiéfin G, Simsek H, Wahlin S. Efe C, et al. Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1308-11. doi: 10.1097/MEG.0b013e328361c704. Eur J Gastroenterol Hepatol. 2013. PMID: 23628974
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
Efe C, Taşçılar K, Gerussi A, Bolis F, Lammert C, Ebik B, Stättermayer AF, Cengiz M, Gökçe DT, Cristoferi L, Peralta M, Massoumi H, Montes P, Cerda E, Rigamonti C, Yapalı S, Adali G, Çalışkan AR, Balaban Y, Eren F, Eşkazan T, Barutçu S, Lytvyak E, Zazueta GM, Kayhan MA, Heurgue-Berlot A, De Martin E, Yavuz A, Bıyık M, Narro GC, Duman S, Hernandez N, Gatselis NK, Aguirre J, Idilman R, Silva M, Mendizabal M, Atay K, Güzelbulut F, Dhanasekaran R, Montano-Loza AJ, Dalekos GN, Ridruejo E, Invernizzi P, Wahlin S. Efe C, et al. Among authors: heurgue berlot a. J Autoimmun. 2022 Oct;132:102906. doi: 10.1016/j.jaut.2022.102906. Epub 2022 Sep 7. J Autoimmun. 2022. PMID: 36088883 Free PMC article.
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis.
Efe C, Ozaslan E, Heurgué-Berlot A, Kav T, Masi C, Purnak T, Torgutalp M, Muratori L, Bresson-Hadni S, Thiéfin G, Schiano TD, Muratori P, Wahlin S. Efe C, et al. Eur J Gastroenterol Hepatol. 2014 May;26(5):532-7. doi: 10.1097/MEG.0000000000000075. Eur J Gastroenterol Hepatol. 2014. PMID: 24614697
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
Efe C, Hagström H, Ytting H, Bhanji RA, Müller NF, Wang Q, Purnak T, Muratori L, Werner M, Marschall HU, Muratori P, Gunşar F, Klintman D, Parés A, Heurgué-Berlot A, Schiano TD, Cengiz M, May-Sien Tana M, Ma X, Montano-Loza AJ, Berg T, Verma S, Larsen FS, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S. Efe C, et al. Among authors: heurgue berlot a. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1950-1956.e1. doi: 10.1016/j.cgh.2017.06.001. Epub 2017 Jun 8. Clin Gastroenterol Hepatol. 2017. PMID: 28603052
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
Efe C, Taşçilar K, Henriksson I, Lytvyak E, Alalkim F, Trivedi H, Eren F, Eliasson J, Beretta-Piccoli BT, Fischer J, Calişkan AR, Chayanupatkul M, Coppo C, Ytting H, Purnak T, Muratori L, Werner M, Muratori P, Rorsman F, Önnerhag K, Günşar F, Nilsson E, Heurgué-Berlot A, Güzelbulut F, Demir N, Gönen C, Semela D, Aladağ M, Kiyici M, Schiano TD, Montano-Loza AJ, Berg T, Ozaslan E, Yoshida EM, Bonder A, Marschall HU, Wahlin S. Efe C, et al. Among authors: heurgue berlot a. Am J Gastroenterol. 2019 Jul;114(7):1101-1108. doi: 10.14309/ajg.0000000000000290. Am J Gastroenterol. 2019. PMID: 31241547
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome.
Efe C, Torgutalp M, Henriksson I, Alalkim F, Lytvyak E, Trivedi H, Eren F, Fischer J, Chayanupatkul M, Coppo C, Purnak T, Muratori L, Werner M, Muratori P, Rorsman F, Onnerhag K, Nilsson E, Heurgué-Berlot A, Demir N, Semela D, Kıyıcı M, Schiano TD, Montano-Loza AJ, Berg T, Ozaslan E, Yoshida EM, Bonder A, Marschall HU, Beretta-Piccoli BT, Wahlin S. Efe C, et al. Among authors: heurgue berlot a. J Gastroenterol Hepatol. 2021 Apr;36(4):936-942. doi: 10.1111/jgh.15214. Epub 2020 Aug 23. J Gastroenterol Hepatol. 2021. PMID: 32790935
Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
Ben Merabet Y, Barbe C, Heurgue-Berlot A, Thévenot T, Minello A, Habersetzer F, Samuel D, Bernard-Chabert B, Weil-Verhoeven D, Renard P, Clot H, Di Martino V, Louvet H, Bresson-Hadni S, Thiéfin G. Ben Merabet Y, et al. Among authors: heurgue berlot a. Dig Dis Sci. 2021 Jun;66(6):2107-2117. doi: 10.1007/s10620-020-06444-7. Epub 2020 Jun 30. Dig Dis Sci. 2021. PMID: 32607807
25 results